A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults.

Details

Language :

English

ISSN :

21645515

Volume :

17

Issue :

5

Database :

Complementary Index

Journal :

Human Vaccines & Immunotherapeutics

Publication Type :

Academic Journal

Accession number :

149906841

Full Text :

https://doi.org/10.1080/21645515.2020.1829899